Antengene Corporation Limited (HKG:6996)
Hong Kong
· Delayed Price · Currency is HKD 4.040
+0.100 (2.54%)
Jun 10, 2025, 1:42 PM HKT
Antengene Corporation Revenue
In the year 2024, Antengene Corporation had annual revenue of 91.95M CNY with 36.62% growth. Antengene Corporation had revenue of 31.17M in the half year ending December 31, 2024, a decrease of -70.64%.
Revenue
91.95M CNY
Revenue Growth
+36.62%
P/S Ratio
27.36
Revenue / Employee
544.08K CNY
Employees
169
Market Cap
2.68B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 32.53B |
| Hansoh Pharmaceutical Group Company | 13.05B |
| JD Health International | 61.89B |
| Innovent Biologics | 10.03B |
| CSPC Pharmaceutical Group | 28.99B |
| WuXi Biologics | 19.87B |
| Sino Biopharmaceutical | 30.72B |
| Sichuan Kelun-Biotech Biopharmaceutical | 2.06B |